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1. Introduction 
We have presented evidence that in human red 
blood cells (RBC) NADH-cytochrome b5 reductase 
(EC 1.6.2.2.) is not only soluble, but also tightly 
bound to the inner face of the membrane [I]. The 
membrane-bound enzyme is: (i) unmasked by Triton 
X-100 treatment; and (ii) solub~~zed by cathepsin D 
treatment. A structural relationship between the 
membrane-bound enzyme and the native soluble 
enzyme has been established on i~unolo~c and 
genetic evidence [I]. On those grounds we have pos- 
tulated that the soluble cytochrome bS reductasc of 
the human RBC, already known to play a major role 
in metl~emo~obin reduction, derives from the mem- 
brane-bound entity through proteolytic cleavage, 
Here we show that, indeed, the human red-cell 
membrane contains a proteolytic activity which trans- 
forms the membrane-bound form into the soluble one. 
By Hugh-speed gel permeation chromatog~phy (GPC) 
on TSK 250 gel, we compared the molecular weight 
(or M,) of: 
(i) The native ~nembrane-bound enzyme treated by 
Triton X-100; 
(ii) The spontaneously soluble form; 
(iii> The soluble form released by cathepsin D treat- 
ment of the membrane; 
(iv) The soluble form released by endogenous mem- 
brane protease( 
We found that the membrane bound enzyme was 
Iw, 45 000 whereas the spontaneously soluble enzyme 
was iw, 29 000. This value was similar to that obtained 
after solub~ization of the membrane bound enzyme 
by cathepsin D treatment and by endogenous autol- 
ysis. 
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2. Material and methods 
RBC 
(i) S~u~~~~~~~zi~~v ~) ub~~ enzyme The red cell solu- 
ble cytochrome bs reductase was partially purified as 
in 121. 
(ii) M~r?z~~arze-~ourz~ r~z~rr~~ The RISC memb~dnes 
were prepared according to [3]. The ghosts were sus- 
pended in a 10 mM Tris-HC1 buffer (pH 7.4) con- 
ta~~g 2% Triton X-100. After 30 min incubation at 
4°C the suspension was frozen and thawed 3 times 
and centrifuged for 10 min (10.5 000 X g) at 4°C 
(Airfuge ~eckman~. The supernatant was collected 
for further analysis. 
(iii} ~at~~~~~~~rl R-released enzyme The membranes 
were incubated for 2 h at 37°C in 0.1 M Tris-maleate 
buffer @I 5.6) in the presence of cathepsin D, Sigma 
(5 @g/l 00 (lg membrane proteins). The solubilized 
enzyme was studied in the 10.5 000 X R superI~t~nt 
obtained as above. 
(iv) Etzzyme sohbilized bv erdogenous membrarze 
~r~~~~s~ ~~t~~~~v The membrane suspension was 
incubated for 2 h at 3’7’C in Tris-maleate 0.1 M 
t’pH 5.6) buffer in the presence of 1% Triton X-100. 
After incubation the 305 000 X p supernatant was 
analysed, 
2.2. Brzyn_2e assays 
NADH-cytochr~me bS reductase activity was 
assayed according to 141, in which the rate of reduc- 
tion of a fcrrocyan~de-~~~ethe~no~obin c mplex is 
followed. 
2.3. nil, ~~t~rrn~~ati~~~ 
Gel permeation chromatography (GPC) was per- 
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formed on a Chromatem 38 (Touzart et Matignon, 
Ivry) liquid chromatograph equipped with a 
300 X 7.5 mm Bio Silk TSK 250 column (Biorad). 
The eluent was Tris-HCI 0.05 M, EDTA 0.001 M 
(PH 7.4) with or without 1% Triton X-100. The flow 
rate was 0.7 ml/mm. The column was calibrated by: 
cytochrome c (M, 12 500); a-chymotrypsinogen A 
(M, 25 000); ovalbumin (M, 45 000); and bovine serum 
albumin (M, 68 000). 
Each marker protein (5 pg in 5-20 ~1) was applied 
onto the column. Detection was performed at 280 nm 
(Altex). For the analysis of the different samples con- 
taming cytochrome b5 reductase, 10 pg protein was 
applied onto the column. Fractions of 350 ~1 were 
collected each 30 s and the enzymatic activity was 
determined on aliquots of 100 ~1 [4]. 
3. Results 
GPC analyses were done to compare the Mr of the 
spontaneously soluble, solubilized and membrane- 
bound red cell cytochrome b5 reductase. 
The calibration of the column eluted with buffer 
with or without 1% Triton X-l 00 gave identical results, 
using the above markers. Over of 45-12.5 X lo3 M, 
the elution volume was linearly correlated to log Mr 
(fig.1). 
The results obtained with the different enzymatic 
species were the following (fig.2A): 
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Fig.]. MI calibration of Bio Silk TSK 250 column: Elution 
buffer was 50 mM Tris-HCl, 1 mM EDTA (pH 7.4) without 
or with Triton X-l 00 1% final. The flow rate was 0.7 ml/min 
and the pressure 15 bars. Each protein (5 ng) was applied 
onto the column. The protein concentration in the effluent 
was monitored at 280 nm. (1) Bovine serum albumin 
(68 000); (2) ovalbumin (45 000); (3) ol-chymotrypsmogen 
(25 000); (4) cytochrome c (12 500). 
Elution volume(ml) 
Fig.2. Gel permeation chromatography of the different sam- 
ples on a Bio Silk TSK 250 column. Experimental conditions 
are in fig.1. (A) (1) Membranes treated by Triton X-100 2% 
final; (2) cathepsin D released enzyme, and semi-purified 
spontaneously soluble cytochrome b, reductase. Of each 
sample 20 ~1 (-10 fig protein) were applied to the column. 
The detection of the enzyme was performed by enzymatic 
activity assay in each fraction [4]. Results were expressed as 
A . mine’. 100 nl-’ x lo*. (B) Membranes treated by Triton 
X-100 1% fmalandincubated 2 hat 37°C atpH 5.6: (1) resid- 
ual unmodified enzyme; (2) solubilized enzyme. Of suspension 
20 ~1 (.- 10 ng protein) were applied on the column. Enzymatic 
activities were expressed as A . min-’ . 100 ~1~’ X 10’. 
(i) The Triton X-loo-treated membrane enzyme was 
the larger species eluted at a volume correspond-. 
ing to Mr 45 000. 
This result is in good agreement with an experiment 
in which we had determined a M, of 44 000 (unpub- 
lished) by ultracentrifugation in a 5-20% sucrose gra- 
dient according to Martin and Ames. 
(ii) The soluble semi-purified enzyme was demon- 
strated to be smaller than the membrane-asso- 
ciated form. 
By GPC we found M, 29 000. After treatment of the 
ghosts by cathepsin D, the activity was eluted at the 
same volume (8.4 ml). Experiments in which the solu- 
ble and the cathepsin D-solubilized enzyme were 
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mixed and applied together on the column only demon- 
strate a single peak containing the enzymatic activity. 
The analysis of the phenomenon of spontaneous 
release of a soluble species from the red cell membrane 
upon incubation at 37°C is shown in fig.ZB. Two dis- 
tincts peaks containing enzyme activity were observed. 
The first one corresponded to the residual unmodified 
membrane species (Mr 4.5 000) while the second 
showed a Mr identical to that of the soluble forms 
above (29 000). 
4. Discussion 
Since cathepsin D treatment of the red cell mem- 
brane results in the release of a soluble and active spe- 
cies, we had postulated, that in vivo, the spontaneously 
soluble enzyme might be produced by endogenous 
proteolysis of the amphipathic molecule [ 11. These 
results reported support that hypothesis. 
4.1. Met~lod~~o~~ interest o~ge~~e~e~tio~ chro- 
ma tography 
This study shows the great interest of the gel per- 
meation chromatography method. This method is 
very rapid and requires very small quantities of mate- 
rial of the same order as those used in SDS-PAGE. 
Gel permeation chromatography offers the additional 
advantage to allow the recovery of the enzyme in a 
native form, therefore detectable by its activity. The 
use of Triton X-l 00 does not modify the elution pat- 
tern of the markers and the samples. 
4.2. M, value 
The MI of 44-47 X lo3 is in agreement with that 
in [S] for calf liver microsomes, and [6] for rabbit 
liver microsomes. However, it is significantly higher 
than the value of 33 000 observed in (71 on a highly 
purified fraction devoid of detergent. 
Solub~ization of the membrane-bound enzyme by 
either cathepsin D or autoincubation at 37*C in the 
presence of Triton X-l 00 yielded species of the same 
Mr 29-30 X 103. This value is in good agreement 
with data from the literature concerning the proteo- 
lytic cleavage of the amp~pa~ic liver cytochrome bs 
reductase by lysosome or cathepsin D in various ani- 
mals [S-9]. 
Interestingly, the phenomenon of spontaneous 
proteolysis of the red cell membrane-bound enzyme 
does not occur in the absence of Triton X-100. The 
role of the detergent is not known. It might activate a 
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membrane protease or/and unfold the cytochrome b, 
reductase and render it more accessible to endogenous 
proteolysis. In [lo] Triton X-100 solubilized and 
activated red-cell membrane protease( The superna- 
tant of red cell membranes treated by Triton X-l 00 2% 
final, contains 70% of the total proteolytic activity [IO]. 
There is no indication that the point of cleavage 
by endogenous or exogenous (cathepsin D) proteolytic 
attack is rigorously identical. Further studies are 
required to clarify the break point produced between 
the two domains by the endogenous RBC membrane 
protease [5-71. 
The question concerning the proteolytic processing 
of the membrane cytochrome b5 reductase during the 
life-time of the red celI is very important. At which 
precise step of differentiation this occurs remains to 
be determined. The soluble cytochrome b5 reductase 
is reduced by 50% in cord blood and new-born red 
cells [ 1 l] whereas their membrane-bound activity is 
normal (unpublished). It would be interesting to test 
whether this is due to a decreased membrane proteo- 
lytic activity of the cord blood red-cells. This is now 
under investigation. 
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